At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
532nm KTP Laser vs 595nm Pulse Dye Laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Randomized, Controlled Split-Face Study of the Excel V 532nm KTP Laser for the Treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea
In Brief
A clinical study evaluating 532nm KTP Laser vs 595nm Pulse Dye Laser for Erythematotelangiectatic Rosacea and Papulopustular Rosacea. Completed, enrolled 22 participants across 1 site.
Detailed Summary
A single center prospective, randomized, controlled split face study comparing a 532nm KTP laser with a 595nm PDL for the treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea. Subjects will receive laser treatments and will be followed at 6 weeks post-final laser treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartSep 2014
First PostedOct 2014
Primary CompletionAug 2015
TodayJul 2026
First PostedOct 20, 2014
Enrollment StartSep 1, 2014
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.7 years ago
Interventions
532nm KTP Laser vs 595nm Pulse Dye Laserdevice
Intervention for the Cutera Excel V system is to cease treatment to any subject that is experiencing any adverse reaction.